nodes	percent_of_prediction	percent_of_DWPC	metapath
Apraclonidine—Parosmia—Ramipril—type 1 diabetes mellitus	0.00902	0.0817	CcSEcCtD
Apraclonidine—Libido decreased—Ramipril—type 1 diabetes mellitus	0.00458	0.0415	CcSEcCtD
Apraclonidine—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.00421	0.0382	CcSEcCtD
Apraclonidine—Asthma—Ramipril—type 1 diabetes mellitus	0.00367	0.0333	CcSEcCtD
Apraclonidine—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00352	0.0319	CcSEcCtD
Apraclonidine—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.00318	0.0288	CcSEcCtD
Apraclonidine—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.00289	0.0262	CcSEcCtD
Apraclonidine—Visual impairment—Ramipril—type 1 diabetes mellitus	0.00283	0.0257	CcSEcCtD
Apraclonidine—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.00265	0.024	CcSEcCtD
Apraclonidine—Arrhythmia—Ramipril—type 1 diabetes mellitus	0.00263	0.0238	CcSEcCtD
Apraclonidine—Mental disorder—Ramipril—type 1 diabetes mellitus	0.00257	0.0233	CcSEcCtD
Apraclonidine—Erythema—Ramipril—type 1 diabetes mellitus	0.00256	0.0232	CcSEcCtD
Apraclonidine—Tension—Ramipril—type 1 diabetes mellitus	0.00251	0.0227	CcSEcCtD
Apraclonidine—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00251	0.0227	CcSEcCtD
Apraclonidine—Nervousness—Ramipril—type 1 diabetes mellitus	0.00248	0.0225	CcSEcCtD
Apraclonidine—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00237	0.0215	CcSEcCtD
Apraclonidine—Malaise—Ramipril—type 1 diabetes mellitus	0.00231	0.0209	CcSEcCtD
Apraclonidine—Syncope—Ramipril—type 1 diabetes mellitus	0.00229	0.0208	CcSEcCtD
Apraclonidine—Palpitations—Ramipril—type 1 diabetes mellitus	0.00226	0.0205	CcSEcCtD
Apraclonidine—Myalgia—Ramipril—type 1 diabetes mellitus	0.00218	0.0197	CcSEcCtD
Apraclonidine—Chest pain—Ramipril—type 1 diabetes mellitus	0.00218	0.0197	CcSEcCtD
Apraclonidine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.00216	0.0196	CcSEcCtD
Apraclonidine—Discomfort—Ramipril—type 1 diabetes mellitus	0.00215	0.0195	CcSEcCtD
Apraclonidine—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00213	0.0193	CcSEcCtD
Apraclonidine—Oedema—Ramipril—type 1 diabetes mellitus	0.00209	0.0189	CcSEcCtD
Apraclonidine—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.00205	0.0185	CcSEcCtD
Apraclonidine—Skin disorder—Ramipril—type 1 diabetes mellitus	0.00203	0.0184	CcSEcCtD
Apraclonidine—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.0019	0.0172	CcSEcCtD
Apraclonidine—Insomnia—Ramipril—type 1 diabetes mellitus	0.00189	0.0171	CcSEcCtD
Apraclonidine—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00187	0.017	CcSEcCtD
Apraclonidine—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00186	0.0169	CcSEcCtD
Apraclonidine—Somnolence—Ramipril—type 1 diabetes mellitus	0.00186	0.0168	CcSEcCtD
Apraclonidine—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.0018	0.0163	CcSEcCtD
Apraclonidine—Fatigue—Ramipril—type 1 diabetes mellitus	0.0018	0.0163	CcSEcCtD
Apraclonidine—Constipation—Ramipril—type 1 diabetes mellitus	0.00179	0.0162	CcSEcCtD
Apraclonidine—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00172	0.0156	CcSEcCtD
Apraclonidine—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00171	0.0155	CcSEcCtD
Apraclonidine—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00165	0.015	CcSEcCtD
Apraclonidine—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.00154	0.0139	CcSEcCtD
Apraclonidine—Asthenia—Ramipril—type 1 diabetes mellitus	0.0015	0.0136	CcSEcCtD
Apraclonidine—Pruritus—Ramipril—type 1 diabetes mellitus	0.00148	0.0134	CcSEcCtD
Apraclonidine—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.00143	0.0129	CcSEcCtD
Apraclonidine—Dizziness—Ramipril—type 1 diabetes mellitus	0.00138	0.0125	CcSEcCtD
Apraclonidine—Vomiting—Ramipril—type 1 diabetes mellitus	0.00133	0.012	CcSEcCtD
Apraclonidine—Dermatitis—Ramipril—type 1 diabetes mellitus	0.00132	0.0119	CcSEcCtD
Apraclonidine—Headache—Ramipril—type 1 diabetes mellitus	0.00131	0.0118	CcSEcCtD
Apraclonidine—Nausea—Ramipril—type 1 diabetes mellitus	0.00124	0.0112	CcSEcCtD
Apraclonidine—ADRA1A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000777	0.000873	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000777	0.000873	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ITPR3—type 1 diabetes mellitus	0.000772	0.000867	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000758	0.000853	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IGF2—type 1 diabetes mellitus	0.000757	0.00085	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000755	0.000849	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000754	0.000848	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000744	0.000837	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ABCC8—type 1 diabetes mellitus	0.000742	0.000834	CbGpPWpGaD
Apraclonidine—ADRA2A—Platelet activation, signaling and aggregation—IL2—type 1 diabetes mellitus	0.000724	0.000814	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR ligand binding—CCR5—type 1 diabetes mellitus	0.000723	0.000812	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000722	0.000812	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—NOS2—type 1 diabetes mellitus	0.000722	0.000812	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IAPP—type 1 diabetes mellitus	0.000722	0.000811	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000717	0.000805	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000708	0.000796	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000705	0.000793	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000705	0.000793	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ITPR3—type 1 diabetes mellitus	0.000701	0.000788	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000696	0.000782	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000695	0.000782	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000694	0.00078	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000682	0.000767	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000679	0.000763	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000676	0.00076	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—NOS2—type 1 diabetes mellitus	0.000674	0.000758	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000669	0.000752	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IAPP—type 1 diabetes mellitus	0.000655	0.000737	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000654	0.000735	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000651	0.000731	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.00065	0.000731	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000648	0.000729	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000646	0.000727	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000646	0.000727	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IGF1—type 1 diabetes mellitus	0.00064	0.00072	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2RA—type 1 diabetes mellitus	0.000637	0.000716	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—SST—type 1 diabetes mellitus	0.000634	0.000712	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000632	0.00071	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000631	0.00071	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—ADRB1—type 1 diabetes mellitus	0.000631	0.000709	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.00063	0.000708	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000619	0.000696	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000617	0.000693	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000611	0.000686	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ITPR3—type 1 diabetes mellitus	0.000609	0.000685	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 1 diabetes mellitus	0.000609	0.000685	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000608	0.000683	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000608	0.000683	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000608	0.000683	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—ALB—type 1 diabetes mellitus	0.000607	0.000682	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000604	0.000679	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000604	0.000679	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IGF1—type 1 diabetes mellitus	0.000598	0.000672	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.00059	0.000664	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000589	0.000662	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000587	0.000659	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000585	0.000658	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—NOS3—type 1 diabetes mellitus	0.00058	0.000652	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—SST—type 1 diabetes mellitus	0.000575	0.000647	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—HBA1—type 1 diabetes mellitus	0.000574	0.000645	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—ADRB1—type 1 diabetes mellitus	0.000573	0.000644	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—APOC3—type 1 diabetes mellitus	0.00057	0.000641	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000568	0.000639	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000568	0.000638	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—ALB—type 1 diabetes mellitus	0.000567	0.000637	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000567	0.000637	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—GCG—type 1 diabetes mellitus	0.000565	0.000635	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GSTT1—type 1 diabetes mellitus	0.00056	0.000629	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000552	0.00062	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—NOS2—type 1 diabetes mellitus	0.000548	0.000616	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000546	0.000613	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—PRKCQ—type 1 diabetes mellitus	0.000544	0.000611	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—NOS3—type 1 diabetes mellitus	0.000542	0.000609	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000538	0.000605	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000534	0.0006	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000531	0.000597	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.00053	0.000596	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—VAV1—type 1 diabetes mellitus	0.000528	0.000594	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.000528	0.000593	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.000528	0.000593	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CXCL10—type 1 diabetes mellitus	0.000527	0.000592	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000516	0.00058	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000515	0.000578	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000513	0.000577	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—GCG—type 1 diabetes mellitus	0.000513	0.000577	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.00051	0.000574	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.00051	0.000574	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.00051	0.000573	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000503	0.000565	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000496	0.000558	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000496	0.000558	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000495	0.000557	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ITPR3—type 1 diabetes mellitus	0.000495	0.000556	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—PRKCQ—type 1 diabetes mellitus	0.000494	0.000555	CbGpPWpGaD
Apraclonidine—ADRA2B—Hemostasis—IL2—type 1 diabetes mellitus	0.000492	0.000553	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00049	0.000551	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00049	0.000551	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000489	0.000549	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IGF1—type 1 diabetes mellitus	0.000486	0.000546	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000482	0.000541	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00048	0.000539	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—VAV1—type 1 diabetes mellitus	0.000479	0.000539	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CXCL10—type 1 diabetes mellitus	0.000478	0.000537	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000477	0.000536	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000477	0.000536	CbGpPWpGaD
Apraclonidine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 1 diabetes mellitus	0.000468	0.000526	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—HBA1—type 1 diabetes mellitus	0.000466	0.000524	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—APOC3—type 1 diabetes mellitus	0.000463	0.00052	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000461	0.000518	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—ALB—type 1 diabetes mellitus	0.00046	0.000518	CbGpPWpGaD
Apraclonidine—ADRA2C—Hemostasis—IL2—type 1 diabetes mellitus	0.00046	0.000517	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000457	0.000513	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GSTT1—type 1 diabetes mellitus	0.000455	0.000511	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.00045	0.000506	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—SST—type 1 diabetes mellitus	0.000448	0.000504	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—GCG—type 1 diabetes mellitus	0.000446	0.000501	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000446	0.000501	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000446	0.000501	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—NOS3—type 1 diabetes mellitus	0.00044	0.000495	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000439	0.000494	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000433	0.000487	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000419	0.000471	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—SST—type 1 diabetes mellitus	0.000419	0.00047	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000417	0.000468	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000417	0.000468	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000417	0.000468	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000414	0.000465	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—CCR5—type 1 diabetes mellitus	0.000408	0.000459	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2RA—type 1 diabetes mellitus	0.000402	0.000452	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000399	0.000449	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000399	0.000449	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000393	0.000442	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.00039	0.000438	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000387	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000387	0.000435	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000384	0.000432	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—CAT—type 1 diabetes mellitus	0.000378	0.000424	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000373	0.00042	CbGpPWpGaD
Apraclonidine—ADRA2A—Hemostasis—IL2—type 1 diabetes mellitus	0.000373	0.00042	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000373	0.000419	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000372	0.000418	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—CCR5—type 1 diabetes mellitus	0.000371	0.000417	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—SST—type 1 diabetes mellitus	0.000366	0.000411	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2RA—type 1 diabetes mellitus	0.000365	0.000411	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000364	0.000409	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—GCG—type 1 diabetes mellitus	0.000362	0.000407	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000359	0.000404	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000349	0.000392	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000348	0.000391	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—SST—type 1 diabetes mellitus	0.00034	0.000382	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000339	0.000381	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000338	0.00038	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000338	0.00038	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000326	0.000367	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000326	0.000366	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000317	0.000356	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000316	0.000355	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000314	0.000353	CbGpPWpGaD
Apraclonidine—ADRA2B—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000311	0.00035	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000309	0.000347	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—CAT—type 1 diabetes mellitus	0.000307	0.000345	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000305	0.000343	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000304	0.000342	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000304	0.000342	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—GCG—type 1 diabetes mellitus	0.000303	0.000341	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000294	0.00033	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000292	0.000328	CbGpPWpGaD
Apraclonidine—ADRA2C—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.00029	0.000327	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000289	0.000325	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000289	0.000324	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000285	0.00032	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000283	0.000318	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000282	0.000318	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000282	0.000317	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000277	0.000312	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000276	0.00031	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000274	0.000308	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.00027	0.000303	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000266	0.000299	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000266	0.000299	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000264	0.000296	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—TYK2—type 1 diabetes mellitus	0.000257	0.000289	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.000256	0.000288	CbGpPWpGaD
Apraclonidine—ADRA1A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000254	0.000285	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000252	0.000284	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—INS—type 1 diabetes mellitus	0.000251	0.000282	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000247	0.000278	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.00024	0.000269	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000237	0.000267	CbGpPWpGaD
Apraclonidine—ADRA2A—GPCR downstream signaling—IL2—type 1 diabetes mellitus	0.000236	0.000265	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000236	0.000265	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.000234	0.000263	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000232	0.000261	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000231	0.000259	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—ALB—type 1 diabetes mellitus	0.00023	0.000258	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—INS—type 1 diabetes mellitus	0.000224	0.000252	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—ERBB3—type 1 diabetes mellitus	0.000223	0.00025	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000222	0.000249	CbGpPWpGaD
Apraclonidine—ADRA2C—Metabolism—NOS3—type 1 diabetes mellitus	0.00022	0.000247	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CCR5—type 1 diabetes mellitus	0.000219	0.000246	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000217	0.000244	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000216	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	0.000216	0.000243	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	0.000214	0.000241	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	0.00021	0.000236	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	0.000204	0.000229	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000203	0.000228	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000202	0.000227	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.0002	0.000225	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000197	0.000221	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.000194	0.000218	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000187	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	0.000187	0.00021	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000184	0.000207	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	0.000183	0.000206	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	0.00018	0.000203	CbGpPWpGaD
Apraclonidine—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	0.000179	0.000201	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000177	0.000199	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000176	0.000198	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	0.00017	0.000191	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000167	0.000188	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000167	0.000188	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000166	0.000187	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	0.000165	0.000185	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	0.000164	0.000184	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000164	0.000184	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000161	0.000181	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000156	0.000175	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000156	0.000175	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000155	0.000174	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	0.000152	0.000171	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	0.000149	0.000168	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.00014	0.000158	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000136	0.000153	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000136	0.000153	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000136	0.000152	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000131	0.000147	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000128	0.000143	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	0.000127	0.000142	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	0.000127	0.000142	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	0.000126	0.000142	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000119	0.000134	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000115	0.000129	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	0.000107	0.00012	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	0.000104	0.000117	CbGpPWpGaD
Apraclonidine—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	9.8e-05	0.00011	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	9.68e-05	0.000109	CbGpPWpGaD
Apraclonidine—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	9.16e-05	0.000103	CbGpPWpGaD
Apraclonidine—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	8.01e-05	9e-05	CbGpPWpGaD
Apraclonidine—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	7.44e-05	8.36e-05	CbGpPWpGaD
